logo

For the Inventor, By the Inventor

Lincoln, MA, United States of America

Ellis L Reinherz

This inventor holds 15 USPTO granted patents and 2 published patent applications, primarily in Molecular Biology. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College, Sidney Farber Cancer Institute, Inc.. Active years: 1984-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ellis L Reinherz. Retrieved from https://idiyas.com/inventor/ellis-l-reinherz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15 

% Patents Active = 80.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 126(Granted Patents)


Company Filing History:

goldMedal13 out of 1,269 
 
Dana-Farber-Cancer Institute Inc.
 patents
silverMedal1 out of 3,081 
 
Harvard College
 patents
bronzeMedal1 out of 4 
 
Sidney Farber Cancer Institute, Inc.
 patents
4. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2015

Loading Chart...
Areas of Expertise:
Peptide Blocks
T Cell Receptors
Monoclonal Antibodies
Oligonucleotide Array
Caspase Activity
Recombinant DNA
Activated T-Cells
CD2 Binding Protein
CDC15-Like Adaptor Protein
HIV Binding
Molecule Design
Tissue Typing
15 patents (USPTO):Explore Patents
1. 9205144 - Identification of conserved peptide blocks in homologous polypeptides (2015-12-08),
2. 8969254 - Oligonucleotide array for tissue typing (2015-03-03),
3. 8275595 - Computer-based methods of designing molecules (2012-09-25),
4. 7247438 - Methods of identifying agents which enhance caspase activity (2007-07-24),
5. 7091330 - Cloning and characterization of a CD2 binding protein (CD2BP2) (2006-08-15),
6. 6689868 - Cloning and characterization of a CDC 15-like adaptor protein (CD2BP1) (2004-02-10),
7. 6444439 - Cloning and characterization of a cdc15-like adaptor protein (CD2BP1) (2002-09-03),
8. 6416971 - Soluble single chain T cell receptors (2002-07-09),
9. 5830754 - Recombinant DNA-produced T11 and fragments thereof (1998-11-03),
10. 5608037 - Recombinant DNA-produced T11 and fragments thereof (1997-03-04),
11. 5550055 - Recombinant DNA-produced T11 and fragments thereof (1996-08-27),
12. 5109123 - Alteration of ability of soluble CD4 fragments to bind HIV (1992-04-28),
13. 4788137 - Detection of activated T-cells (1988-11-29),
14. 4550086 - Monoclonal antibodies that recognize human T cells (1985-10-29),
15. 4443427 - Monoclonal antibody (1984-04-17),

Title: The Innovative Contributions of Ellis L Reinherz

Introduction

Ellis L Reinherz, based in Lincoln, MA, is a prominent inventor known for his significant contributions in the field of immunology and biotechnology. With a portfolio of 15 patents, he has made substantial advancements that have a lasting impact on medical research and applications.

Latest Patents

Among his latest patents, Reinherz focuses on two notable innovations. The first is the "Identification of Conserved Peptide Blocks in Homologous Polypeptides," which provides methods for identifying conserved peptide blocks in multiple homologous polypeptides. This work has critical implications for selecting conserved peptides in variable viral polypeptides intended for immunogenic compositions. The second patent is an "Oligonucleotide Array for Tissue Typing," which features oligonucleotide-based microarrays for high-resolution tissue typing, particularly useful in diagnostic evaluations and assessing donor/recipient transplant compatibility.

Career Highlights

Reinherz has had an illustrious career, working at esteemed institutions such as the Dana-Farber Cancer Institute and the Sidney Farber Cancer Institute. His innovative research and development efforts have helped advance the understanding and treatment of various diseases, particularly in the realm of cancer and immunotherapy.

Collaborations

Throughout his career, Ellis L Reinherz has collaborated with various professionals, including notable coworkers Peter Sayre and Hsiu-Ching Chang. These collaborations have fostered a creative environment conducive to innovation, producing groundbreaking methodologies and applications in medical science.

Conclusion

Ellis L Reinherz’s contributions to the fields of immunology and biotechnology are notable and impactful. With 15 patents to his name, his work continues to inspire and drive advances in medical research, highlighting the importance of collaboration and innovation in addressing complex scientific challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…